Cargando…
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
Aspirin is widely used in clinical settings as an anti-inflammatory and anti-platelet drug due its inhibitory effect on cyclooxygenase activity. Although the drug has long been considered to be an effective and safe therapeutic regime against inflammatory and cardiovascular disorders, consequences o...
Autores principales: | Nayak, Manasa K., Dash, Ayusman, Singh, Nitesh, Dash, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134270/ https://www.ncbi.nlm.nih.gov/pubmed/25126950 http://dx.doi.org/10.1371/journal.pone.0105049 |
Ejemplares similares
-
Correction: Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
Publicado: (2014) -
Correction to: Plasma Fibrinogen Is a Natural Deterrent to Amyloid β-Induced Platelet Activation and Neuronal Toxicity
por: Sonkar, Vijay K., et al.
Publicado: (2019) -
Aerobic glycolysis fuels platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents
por: Kulkarni, Paresh P., et al.
Publicado: (2019) -
Effects of Nanoceria on Human Platelet Functions and Blood Coagulation
por: Kailashiya, Jyotsna, et al.
Publicado: (2022) -
Aspirin resistance and blood biomarkers in predicting ischemic stroke recurrence: An exploratory study
por: Dash, Prerana, et al.
Publicado: (2022)